The development of new diagnostic marker for pancreatic cancer by use of endoscopic ultrasound-guided fine needle aspiratio
Not Applicable
- Conditions
- Pancreatic Cancer
- Registration Number
- JPRN-UMIN000015871
- Lead Sponsor
- Department of Endoscopy, The Jikei University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who receive anticoagulant drug or antiplatelet drug. 2. Patients affected with acute pancreatitis. 3. Patients undergone already chemotherapy or radiation therapy. 4. Women during pregnancy and of childbearing potential, or presently breastfeeding. 5. Patients who are affected with psychiatric disorder, and can not be enrolled in this clinical trial, due to loss of judgment. 6. Patients who are ruled unfit to enroll this crinical trial, in the judgment of endoscopists or attending doctors.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method i)VEGF-A and Flk-1 expression which obtained from EUS-FNA's specimen and those of surgical specimen, will be copared with each other. ii)To develop a new biomarker for pancreatic cancer diagnosis, the S100P expression is measured.
- Secondary Outcome Measures
Name Time Method